MTVA: MetaVia Inc. Stock

by  •  • Comments Off on MTVA: MetaVia Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 6.40
Enterprise Value ($M) -9.62
Book Value ($M) 7.93
Book Value / Share 0.92
Price / Book 0.81
NCAV ($M) 7.74
NCAV / Share 0.89
Price / NCAV 0.83

Profitability (mra)
Return on Invested Capital (ROIC) -3.42
Return on Assets (ROA) -1.62
Return on Equity (ROE) -2.74

Liquidity (mrq)
Quick Ratio 1.94
Current Ratio 1.94

Balance Sheet (mrq) ($M)
Current Assets 16.07
Assets 16.26
Liabilities 8.33
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -28.81
Net Income -27.59
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -24.71
Cash from Investing -0.01
Cash from Financing 18.30

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G Armistice Capital, Llc 9.99 3.23
09-20 13D/A Dong-a St Co., Ltd 54.95 118.93

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-20 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-21 67,995 258,980 26.25
2025-04-17 152,070 474,090 32.08
2025-04-16 216,046 895,426 24.13

(click for more detail)

Similar Companies
MNPR – Monopar Therapeutics Inc. MRKR – Marker Therapeutics, Inc.
MTEX – Mannatech, Incorporated MYNZ – Mainz Biomed N.V.
NAGE – Niagen Bioscience, Inc.


Financial data and stock pages provided by
Fintel.io